All analyses

Universal Health Services, Inc. (UHS) Stock Analysis

Score A

Compounder · Grade B · Bearish

Healthcare · Medical Care Facilities

$166.61

Fair Value

$322.49

+93.6%

Conviction

10/10

Quality

B

Classification

Compounder

Investment Thesis

Good opportunity: Solid company with good risk/reward at 10.0:1.

For New Investors

Quantitative score: high

For Current Holders

Quantitative score: neutral

Buy if

  • Price drops 15-20% (improves asymmetry)
  • Bull scenario catalysts materialize
  • Market-wide correction creates opportunity

Sell if

  • Bear scenario triggers occur
  • Quality metrics deteriorate (ROIC declining)
  • Better alternatives emerge

Valuation

Fair Value estimate: $322.49 (+93.6%). Significantly undervalued.

PEG-Based EPS

$333.21

FCF DCF Model

$333.21

EV/EBITDA

$333.21

Blended Fair Value

$322.49

Confidence

High

Methods

PEG-Based EPS, FCF 2-Stage DCF, EV/EBITDA

Quality Analysis

B

86/120 points

Investable

ROE (3Y Avg)

16.4%

ROIC-WACC Spread

4.9%

D/E Ratio

0.8x

Current Ratio

1.1x

Interest Coverage

13x

FCF Positive Years

3/3

Quality Flags

  • ROIC spread: 4.9pp (got 12/25 pts)
  • Leverage: D/E 0.8x (9/15 pts)

Market Sentiment

Wall Street Consensus

$211.00

+26.6% Upside

16 analysts

Range: $190.00$310.00

Rating: Buy

Our model aligns with Wall Street consensus.

Trend & Technical

Bearish

Price ($166.58) is 17.0% below SMA 200 ($200.64). Bearish trend. Caution on entry.

Technical Score53/100

Tech Score 53/100 — Neutral technical picture. Mixed signals across indicators.

Risk & Reward

Asymmetry Ratio

10.00:1

Expected Return

+111.4%

Bull Upside

+200.0%

Bear Downside

-10.0%

Excellent asymmetry: >3:1 ratio. Upside significantly outweighs downside.

Verdict: Very Favorable

Scenario Analysis

Bear

Base

Bull

Buy Zone & Action Plan

See exact entry zones, stop-loss levels, and a personalized action plan.

Access free

AI Executive Summary

Get a detailed AI-written breakdown of the investment thesis, risks, and catalysts.

Access free

Technical Analysis

RSI, MACD, moving averages, trend signals, and momentum indicators.

Access free

Ask AI about this stock

Chat with our AI analyst to ask questions about valuation, risks, or comparisons.

Access free

Frequently Asked Questions

What is the fair value of UHS?

Based on our multi-method conviction analysis, the estimated fair value of Universal Health Services, Inc. (UHS) is $322.49. This is calculated by blending PEG-Based EPS, FCF 2-Stage DCF, EV/EBITDA and applying a quality premium of 0% based on the company's fundamentals. The confidence level of this estimate is high.

Is UHS a buy, sell, or hold?

UHS currently has a BUY rating with a conviction score of 10/10. Good opportunity: Solid company with good risk/reward at 10.0:1. Quantitative score: high.

Is UHS a high-quality stock?

Universal Health Services, Inc. has a quality grade of B (86/120 points), rated as Investable. Key metrics include ROE of 16.4%, ROIC-WACC spread of 4.9%, and D/E ratio of 0.8x.

What type of stock is UHS?

UHS is classified as a "compounder" in our framework. Low dividend (reinvesting): 0.5%, Low P/E: 7.0x, High FCF Yield: 8.1%, Moderate growth: 14.2%, Strong ROE: 20.9%

What do Wall Street analysts say about UHS?

16 Wall Street analysts have a consensus price target of $211.00 for UHS, representing +26.6% upside. Targets range from $190.00 to $310.00. The consensus recommendation is "Buy". Our model aligns with Wall Street consensus.

What are the risks of investing in UHS?

The risk/reward asymmetry ratio for UHS is 10.00:1, rated as Very Favorable. Excellent asymmetry: >3:1 ratio. Upside significantly outweighs downside. The expected return is +111.4%, with bull case upside of +200.0% and bear case downside of -10.0%.

What is the current trend for UHS?

UHS is in a bearish trend. Price ($166.58) is 17.0% below SMA 200 ($200.64). Bearish trend. Caution on entry. The technical score is 53/100.

Related Stock Analyses

Best Stocks to Buy

Get the complete analysis

Scenario targets, buy zones, action plan, executive summary, technical analysis, and AI chat. All free.

Last updated: May 19, 2026 · Framework version 3.7

This analysis is for informational purposes only and should not be considered financial advice. Always do your own research before making investment decisions.